Abeona Therapeutics Inc (ABEO) stock has risen 29.39% over the last 12 months, and the average rating from Wall Street analysts is a Buy. InvestorsObserver’s proprietary ranking system, gives ABEO stock a score of 72 out of a possible 100.
That rank is influenced by a fundamental score of 97. In addition to the average rating from Wall Street analysts, ABEO stock has a mean target price of 9.428. This means analysts expect the stock to increase 219.59% over the next 12 months. ABEO's rank also includes a short-term technical score of 81. The long-term technical score for ABEO is 38.
What's Happening with ABEO Stock Today
Abeona Therapeutics Inc (ABEO) stock is lower by -1.34% while the S&P 500 has risen 0.51% as of 1:44 PM on Tuesday, Aug 11. ABEO is lower by -$0.04 from the previous closing price of $2.99 on volume of 647,216 shares. Over the past year the S&P 500 has risen 17.16% while ABEO has risen 29.39%. ABEO lost -$1.66 per share in the over the last 12 months.
Click Here to get the full Stock Score Report on Abeona Therapeutics Inc (ABEO) Stock.
